References
- Addai-Mensah O, Annani-Akollor ME, Nsafoah FO, Fondjo LA, Owiredu EW, Danquah KO, Duneeh RV, Amponsah FA. Effect of poor glycaemic control on plasma levels and activity of protein C, protein S, and antithrombin III in type 2 diabetes mellitus. PLoS One 14, e0223171, 2019.
- Barrea L, Vetrani C, Verde L, Frias-Toral E, Ceriani F, Cernea S, Docimo A, Graziadio C, Tripathy D, Savastano S, Colao A, Muscogiuri G. Comprehensive approach to medical nutrition therapy in patients with type 2 diabetes mellitus: from diet to bioactive compounds. Antioxidants 12, 904, 2023.
- Barriere DA, Noll C, Roussy G, Lizotte F, Kessai A, Kirby K, Belleville K, Beaudet N, Longpre JM, Carpentier AC, Geraldes P, Sarret P. Combination of high-fat/high-fructose diet and low-dose streptozotocin to model long-term type-2 diabetes complications. Sci Rep 8, 424, 2018.
- Bembde AS. A study of plasma fibrinogen level in type-2 diabetes mellitus and its relation to glycemic control. Indian J Hematol Blood Transfus 28, 105–108, 2012.
- Bene J, Hadzsiev K, Melegh B. Role of carnitine and its derivatives in the development and management of type 2 diabetes. Nutr Diabetes 8, 8, 2018.
- Bergmeyer HU. Methods of enzymatic analysis. Verlag Chemie, Academic Press Inc. Second Edition, New York, London, Vol. 2, 1974.
- Bowe JE, Franklin ZJ, Hauge-Evans AC, King AJ, Persaud SJ, Jones PM. Metabolic phenotyping guidelines: assessing glucose homeostasis in rodent models. J Endocrinol 222, G13–25, 2014.
- Ceriello A, Quatraro A, Marchi E, Barbanti M, Dello Russo P, Lefebvre P, Giugliano D. The role of hyperglycaemia-induced alterations of antithrombin III and factor X activation in the thrombin hyperactivity of diabetes mellitus. Diabet Med 7, 343–348, 1990.
- Chiao YA, Chakraborty AD, Light CM, Tian R, Sadoshima J, Shi X, Gu H, Lee CF. NAD+ redox imbalance in the heart exacerbates diabetic cardiomyopathy. Circ Heart Fail 14, e008170, 2021.
- Cornell NW, Veech RL. Enzymatic measurement of ethanol or NAD in acid extracts of biological samples. Anal Biochem 132, 418–423, 1983.
- De Rosa S, Arcidiacono B, Chiefari E, Brunetti A, Indolfi C, Foti DP. Type 2 diabetes mellitus and cardiovascular disease: genetic and epigenetic links. Front Endocrinol 9, 2, 2018.
- Einarson TR, Acs A, Ludwig C, Panton UH. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007-2017. Cardiovasc Diabetol 17, 83, 2018.
- Fan L, Cacicedo JM, Ido Y. Impaired nicotinamide adenine dinucleotide (NAD+) metabolism in diabetes and diabetic tissues: Implications for nicotinamide-related compound treatment. J Diabetes Investig 11, 1403–1419, 2020.
- Henning RJ. Type-2 diabetes mellitus and cardiovascular disease. Future Cardiol 14, 491–509, 2018.
- Jimenez-Cortegana C, Iglesias P, Ribalta J, Vilarino-Garcia T, Montanez L, Arrieta F, Aguilar M, Duran S, Obaya JC, Becerra A, Pedro-Botet J, Sanchez-Margalet V. Nutrients and dietary approaches in patients with type 2 diabetes mellitus and cardiovascular disease: a narrative review. Nutrients 13, 4150, 2021.
- Kuchmerovska T, Shymanskyy I, Chlopicki S, Klimenko A. 1-methylnicotinamide (MNA) in prevention of diabetes-associated brain disorders. Neurochem Int 56, 221–228, 2010.
- Kuchmerovska TM, Dyakun KO, Guzyk MM, Yanytska LV, Pryvrotska IB. Effects of a combined mitochondria-targeted treatment on the state of mitochondria and synaptic membranes from the brains of diabetic rats. Neurophysiology 51, 1–14, 2019.
- Kuchmerovska T, Yanitska L, Horkunenko O, Guzyk M, Tykhonenko T, Pryvrotska I. Nicotinamide prevention in diabetes-induced alterations in the rat liver. Endocr Regul 57, 279–291, 2023.
- Kuchmerovska T, Tykhonenko T, Yanitska L, Savosko S, Pryvrotska I. Nicotinamide and nicotinoyl-gamma-amino-butyric acid as neuroprotective agents against type 1 diabetes-induced nervous system impairments in rats. Neurochem Res 50, 1, 2025.
- Li X, Weber NC, Cohn DM, Hollmann MW, DeVries JH, Hermanides J, Preckel B. Effects of hyperglycemia and diabetes mellitus on coagulation and hemostasis. J Clin Med 10, 2419, 2021.
- Liu F, Lv J, Chen Y, Wang L, Liu Z, Li X. Lipoic acid in metabolic dysfunction-associated steatotic liver disease: a review. Nutr Metab 22, 56, 2025.
- Lowe GD, Rumley A, Mackie IJ. Plasma fibrinogen. Ann Clin Biochem 41, 430–440, 2004.
- Lozano I, Van der Werf R, Bietiger W, Seyfritz E, Peronet C, Pinget M, Jeandidier N, Maillard E, Marchioni E, Sigrist S, Dal S. High-fructose and high-fat diet-induced disorders in rats: impact on diabetes risk, hepatic and vascular complications. Nutr Metab 13, 15, 2016.
- Lu X, Xie Q, Pan X, Zhang R, Zhang X, Peng G, Zhang Y, Shen S, Tong N. Type 2 diabetes mellitus in adults: pathogenesis, prevention and therapy. Sig Transduct Target Ther 9, 262, 2024.
- Luzak B, Boncler M, Kosmalski M, Mnich E, Stanczyk L, Przygodzki T, Watala C. Fibrinogen glycation and presence of glucose impair fibrin polymerization-an in vitro study of isolated fibrinogen and plasma from patients with diabetes mellitus. Biomolecules 10, 877, 2020.
- Marushchak M, Kozak K, Krynytska I. Comorbid overweight/obesity and chronic pancreatitis exacerbate the dyslipidemia progression in type 2 diabetic patients. Endocr Regul 56 168–177, 2022.
- Pechlivani N, Ajjan RA. Thrombosis and vascular inflammation in diabetes: mechanisms and potential therapeutic targets. Front Cardiovasc Med 5, 1, 2018.
- Pieters M, van Zyl DG, Rheeder P, Jerling JC, Loots du T, van der Westhuizen FH, Gottsche LT, Weisel JW. Glycation of fibrinogen in uncontrolled diabetic patients and the effects of glycaemic control on fibrinogen glycation. Thromb Res 120, 439–446, 2007.
- Potaskalova V, Khaitovych M, Plenova O, Valigura M. Thrombose-preventive influence of quercetin in rats on the hypercoagulation diet. Med Sci Ukraine 15, 19–23, 2019.
- Razak MKA, Sultan AA. The importance of measurement of plasma fibrinogen level among patients with type-2 diabetes mellitus. Diabetes Metab Syndr 13, 1151–1158, 2019.
- Roshan TM, Stein N, Jiang XY. Comparison of clot-based and chromogenic assay for the determination of protein c activity. Blood Coagul Fibrinolysis 30, 156–160. 2019.
- Rochette L, Ghibu S, Richard C, Zeller M, Cottin Y, Vergely C. Direct and indirect antioxidant properties of α-lipoic acid and therapeutic potential. Mol Nutr Food Res 57, 114–125, 2013.
- Ruggenenti P, van der Meer IM, Remuzzi G. Oral acetyl-L-carnitine therapy and insulin resistance. Hypertension 55, e26, 2010.
- Sandrini L, Ieraci A, Amadio P, Zara M, Barbieri SS. Impact of acute and chronic stress on thrombosis in healthy individuals and cardiovascular disease patients. Int J Mol Sci 21, 7818, 2020.
- Senesi P, Ferrulli A, Luzi L, Terruzzi I. Diabetes mellitus and cardiovascular diseases: nutraceutical interventions related to caloric restriction. Int J Mol Sci 22, 7772, 2021.
- Shoyaib AA, Archie SR, Karamyan VT. Intraperitoneal route of drug administration should it be used in experimental animal studies? Pharm Res 37, 12, 2019.
- Sillen M, Declerck PJ. Targeting PAI-1 in cardiovascular disease: structural insights into PAI-1 functionality and inhibition. Front Cardiovasc Med 7, 622473, 2020.
- Sobczak AIS, Stewart AJ. Coagulatory defects in type-1 and type-2 diabetes. Int J Mol Sci 20, 6345, 2019.
- Speelman T, Dale L, Louw A, Verhoog NJD. The association of acute phase proteins in stress and inflammation-induced T2D. Cells 11, 2163, 2022.
- Sharma G, Ashhar MU, Aeri V, Katare DP. Development and characterization of late-stage diabetes mellitus and -associated vascular complications. Life Sci 216, 295–304, 2019.
- Talat A, Khan TB, Mahmood S, Aftab S, Zia MA, Khursheed R. Effect of vitamins C and E alone and in combination with each other on LDL and fibrinogen in streptozotocin induced diabetic rats. Ann King Edward Med Univ 17, 70, 2011.
- Tykhonenko Т, Guzyk M, Tykhomyrov A, Korsa V, Yanitska L, Kuchmerovska T. Modulatory effects of vitamin B3 and its derivative on the levels of apoptotic and vascular regulators and cytoskeletal proteins in diabetic rat brain as signs of neuroprotection. Biochim Biophys Acta Gen Subj 1866, 130207, 2022.
- Wickramasinghe ASD, Attanayake AP, Kalansuriya P. Biochemical characterization of high fat diet fed and low dose streptozotocin induced diabetic Wistar rat model. J Pharmacol Toxicol Methods 113, 107144, 2022.
- Williamson DH, Lund P, Krebs HA. The redox state of free nicotinamide-adenine dinucleotide in the cytoplasm and mitochondria of rat liver. Biochem J 103, 514–527, 1967.